Zhansheng S. Jia
169 Changle Xi Road
Xi'an, 710032, China
Xi'an, 710032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
BMSC therapy alleviates conA-induced acute immune mediated liver injury via mir-27b-5p-mediated inhibition of the MARCO/NF-κB axis and macrophage M1 polarization.
Journal: Pathology, research and practice
Published: June 29, 2026
Lectin-based glycoproteomic profiling reveals salivary N-glycan changes recognized by Datura stramonium agglutinin in hepatitis B-related cirrhosis.
Journal: Carbohydrate research
Published: February 06, 2026
A Histone Deacetylase Activity Model for the Discovery and Validation of Sepsis Biomarkers.
Journal: Endocrine, metabolic & immune disorders drug targets
Published: November 19, 2025
GAS6 as a potential target to alleviate neuroinflammation during Japanese encephalitis in mouse models.
Journal: Journal of neuroinflammation
Published: March 19, 2024
PD-L1 expression levels in mesenchymal stromal cells predict their therapeutic values for autoimmune hepatitis.
Journal: Stem cell research & therapy
Published: April 18, 2023
The Comparison of Inflammatory Cytokines (IL-6 and IL-18) and Immune Cells in Japanese Encephalitis Patients With Different Progression.
Journal: Frontiers in cellular and infection microbiology
Published: December 01, 2021
Efficacy and Safety of All-oral Emitasvir and Sofosbuvir in Patients with Genotype 1b HCV Infections without Cirrhosis.
Journal: Journal of clinical and translational hepatology
Published: April 13, 2020
LPS stimulation during HCV infection induces MMP/TIMP1 imbalance in macrophages.
Journal: Journal of medical microbiology
Published: April 04, 2020
Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-arm, open-label, phase 3 trial.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 02, 2020
RIPK3 Promotes JEV Replication in Neurons via Downregulation of IFI44L.
Journal: Frontiers in microbiology
Published: November 26, 2019
Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naïve Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China.
Journal: Journal of clinical and translational hepatology
Published: July 30, 2019
A phase II, single-arm, open-label, multicenter clinical study to evaluate the efficacy and safety of sofosbuvir combined with ribavirin in patients with genotype 2 chronic hepatitis C virus infection
Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: June 11, 2019
Last Updated: 09/26/2026